FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2015/03/005599 [Registered on: 04/03/2015] Trial Registered Retrospectively
Last Modified On: 08/01/2015
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Comparative Clinical study of Pushkarmulaadi churna in ASTHMA 
Scientific Title of Study   A Comparative Clinical study of Pushkarmulaadi churna with Anupana Bheda in the Management of Tamak Shavas with special reference to Bronchial Asthma 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr R K Pareek 
Designation  HOD 
Affiliation  Desh Bhagat University 
Address  PG School of Ayurveda and Research , MGG
PG School of Ayurveda and Research , MGG
Fatehgarh Sahib
PUNJAB
147301
India 
Phone  09416281568  
Fax    
Email  dbacandh@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pooja khurana 
Designation  P.G. Scholar 
Affiliation  Desh Bhagat University 
Address  PG School of Ayurveda and Research , MGG
PG School of Ayurveda and Research , MGG
Fatehgarh Sahib
PUNJAB
147301
India 
Phone  09466303035  
Fax    
Email  drpoojakhuranamalik@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pooja khurana 
Designation  P.G. Scholar 
Affiliation  Desh Bhagat University 
Address  PG School of Ayurveda and Research , MGG
PG School of Ayurveda and Research , MGG
Jalandhar
PUNJAB
147301
India 
Phone  09466303035  
Fax    
Email  drpoojakhuranamalik@gmail.com  
 
Source of Monetary or Material Support  
Desh Bhagat Hospital,MGG 
 
Primary Sponsor  
Name  Desh Bhagat University 
Address  Desh Bhagat University PG school of Ayurveda and Research,MGG 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Desh Bhagat University  Dept of Kayachikista, PG school of Ayurveda and Research,MGG 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr R K Pareek  Desh Bhagat Hospital  Kayachikitsa department,PG School of Ayurveda and research,Desh Bhagat Hospital,Mandi Gobindgarh,PUNJAB
Fatehgarh Sahib
PUNJAB 
9416281568

dbacandh@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PG school of Ayurveda and Research,Desh Bhagat University,Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients having signs and symptoms of Tamak Shavas(Cough, Shortness of Breath,Expiratory wheeze etc.).,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Pushkarmulaadi churna with honey as anupana   Pushkarmulaadi churna with luek warm water in GpI and with honey in gp II and trial duration is 60 days in each group 
Comparator Agent  Pushkarmulaadi churna( Inula racemosa)  Pushkarmulaadi churna with luke warm water in Gp I and with Honey in GP II and trial duration is 60 days in each group  
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  a) Patients willing for trial.
b) Both male and female patients of agebetween 16 years to 80 years.
c) Patients having signs and symptoms of Tamak Shavas(Cough, Shortness of
Breath,Expiratory wheeze etc.).
d) Night symptoms > twice per month.
e) Patients not having any state mentioned in exclusion criteria.
 
 
ExclusionCriteria 
Details  Exclusion criteria:-
a) Patients unwilling to participate in the trial.
b) Patients of age below 16 years and more than 80 years.
c) Alcoholics and drug abuses.
d) Pregnant and lactating women.
e) Severe cases of asthma with complication like suspected infections,large airway lesion,Status asthmatics etc.Cardiaccomplaints,other chronic disease T.B,AIDS,DiabetesMellitus,other systemic and endocrine complaints associated with any degree of asthma.
 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
After completion of the trial period, the data obtained in both groups will be recorded, tabulated and statically analyzed using appropriate test   After completion of the trial period, the data obtained in both groups will be recorded, tabulated and statically analyzed using appropriate test  
 
Secondary Outcome  
Outcome  TimePoints 
data obtained in both groups will be recorded  data obtained in both groups will be recorded 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/09/2014 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL yet in trial 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

 

Tamak shavasa (bronchial asthma) is considered as main disease of Pranvahastrotas                               ( Respiratory tract). Bronchial Asthma is characterized by Paroxysm of dyspnoea accompanied by wheezing resulting from narrowing of Bronchial airways by muscle spasm, mucosal swelling or viscid secretions. As stated by W.H.O. 100-150 million of global population are suffering from Bronchial Asthma. In today stressfull modern urbanized living, incidence of Asthma is considerably increasing. The rapid industrialization, increasing pollution and excessive crowding are some of the factors responsible for the increase of Bronchial Asthma Disease. In modern it is mainly treated with steroids  that actually weakens the lungs when used for long term and come with many other side effects such as dryness, candida or yeast infection, lowered immunity, thinning of bronchiols rashes , Psoriasis and many more. So there is need of safe and effective medicine in Ayurveda for the Treatment and Management of Tamak Shvasa( Bronchial asthma). Pushkarmulaadi churna is selected for trial. In one group Pushkarmulaadi Churna was given with luke warm water and  in another group Pushkarmulaadi Churna was given with Honey.

 
Close